Johnson & Johnson to buy heart device maker Abiomed in $16.6bn deal Financial Times | Nov 1, 2022 at 1:24 PM …Johnson & Johnson has agreed to buy cardiovascular technology group Abiomed for $16.6bn, including debt, a sign that mega dealmaking remains robust in the US…